Nanovaccine for immunotherapy and reduced hepatitis-B virus in humanized model

References

• Dandri M, Burda MR, Török E, et al. Repopulation of mouse liver with human hepatocytes and in vivo infection with hepatitis B virus. Hepatology. 2001;33:981–988.
   PubMed Web of Science ®Google Scholar
• Marrocco C, Rinalducci S, Mohamadkhani A, et al. Blood transfus plasma gelsolin protein: a candidate biomarker for hepatitis B-associated liver cirrhosis identified by proteomic approach. Blood Transfus. 2010;8:s105–s112.
   PubMed Web of Science ®Google Scholar
• Norman G. Hepatitis B: diagnosis, prevention, and treatment. Clin Chem. 1997;43:1500–1506.
   PubMed Web of Science ®Google Scholar
• Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49:S13–S21.
   PubMed Web of Science ®Google Scholar
• Patterson LJ, Aberdeen A, Kone J, et al. Formation of HIV-1 envelope-hepatitis B core antigen hybrids with high affinity for CD4. Biochem Biophys Res Commun. 2001;285:639–643.
   PubMed Web of Science ®Google Scholar
• Pol S. Immunotherapy of chronic hepatitis B by anti HBV vaccine. Biomed Pharmacother. 1995;49:105–109.
   PubMed Web of Science ®Google Scholar
• Chien RN, Liaw YF. Nucleos(t)ide analogues for hepatitis B virus: strategies for long-term success. Best Pract Res Clin Gastroenterol. 2008;22:1081–1092.
   PubMed Web of Science ®Google Scholar
• Bisceglie AMD. Combination therapy for hepatitis B. Gut. 2002;50:443–445.
   PubMed Web of Science ®Google Scholar
• Pol S, Michel ML. Therapeutic vaccination in chronic hepatitis B virus carriers. Expert Rev Vaccines. 2006;5:707–716.
   PubMed Web of Science ®Google Scholar
• Penna A, Artini M, Cavalli A, et al. Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest. 1996;98:1185–1194.
   PubMed Web of Science ®Google Scholar
• Rehermann B, Lau D, Hoofnagle JH, et al. Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest. 1996;97:1655–1665.
   PubMed Web of Science ®Google Scholar
• Bocher WO, Galun E, Marcus H, et al. Reduced hepatitis B virus surface antigen- specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the trimera mouse. Hepatology. 2000;31:480–487.
   PubMed Web of Science ®Google Scholar
• Huang LR, Wu HL, Chen PJ, et al. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci USA. 2006;103:17862–17867.
   PubMed Web of Science ®Google Scholar
• Wen YM, Wu XH, Hu DC, et al. Hepatitis B vaccine and anti-HBs complex as approach for vaccine therapy. Lancet. 1995;345:1575–1576.
   PubMed Web of Science ®Google Scholar
• Liang S, Du J, Yan H, et al. A mouse model for studying the clearance of hepatitis B virus in-vivo using a luciferase reporter. PLoS One. 2013;8:495–500.
   Web of Science ®Google Scholar
• Bocher WO, Marcus H, Shakarchy R, et al. Antigen-specific B and T cells in human/mouse radiation chimera following immunization in vivo. Immunology. 1999;96:634–641.
   PubMed Web of Science ®Google Scholar
• Inuzuka T, Takahashi K, Chiba T, et al. Mouse models of hepatitis B virus infection comprising host-virus immunologic interactions. Pathogens. 2014;3:377–389.
   PubMedGoogle Scholar
• Lubin I, Segall H, Marcus H, et al. Engraftment of human peripheral blood lymphocytes in normal strains of mice. Blood. 1994;83:2368–2381.
   PubMed Web of Science ®Google Scholar
• Yao X, Zheng B, Zhou J, et al. Therapeutic effect of hepatitis B surface antigen-antibody complex is associated with cytolytic and non-cytolytic immune responses in hepatitis B patients. Vaccine. 2007;25:1771–1779.
   PubMed Web of Science ®Google Scholar
• Kosinska AD, Liu J, Lu M, et al. Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck. Med Microbiol Immunol. 2015;204:103–114.
   PubMed Web of Science ®Google Scholar
• Murphy K. Janeway’s Immunology. 8th ed. New York (NY): Garland Science. 2012.
   Google Scholar
• Marcus H, Burakova T, Shezen E, et al. Human->mouse radiation chimera do not develop Epstein-Barr virus lymphoma. Immunol Lett. 1996;49:155–161.
   PubMed Web of Science ®Google Scholar
• Dion S, Bourgine M, Godon O, et al. Adenoassociated virus-mediated gene transfer leads to persistent hepatitis B virus replication in mice expressing HLA-A2 and HLADR1 molecules. J Virol. 2013; 87:5554–5563.
   PubMed Web of Science ®Google Scholar
• Burakova T, Marcus H, Canaan A, et al. Engrafted human T and B lymphocytes form mixed follicles in lymphoid organs of human/mouse and human/rat chimera. Transplantation. 1997;63:1166–1171.
   PubMed Web of Science ®Google Scholar
• Asokan R, Banda NK, Szakonyi G, et al. Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE). Mol Immunology. 2013;53:99–110.
   PubMed Web of Science ®Google Scholar
• Reisner Y, Dagan S. The Trimera mouse: a novel system for the generation of human monoclonal antibodies and models for human diseases. Trends Biotechnol. 1998;16:242–246.
   PubMed Web of Science ®Google Scholar
• Segall H, Lubin I, Marcus H, et al. Generation of primary antigen-specific human cytotoxic T lymphocytes in human/mouse radiation chimera. Blood. 1996;88:721–730.
   PubMed Web of Science ®Google Scholar
• Chisari FV, Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 1995;13:29–60.
   PubMed Web of Science ®Google Scholar
• Larsen SR, Kingham JA, Hayward MD, et al. Damage to incisors after nonmyeloablative total body irradiation may complicate NOD/SCID models of hemopoietic stem cell transplantation. Comp Med. 2006;56:209–214.
   PubMed Web of Science ®Google Scholar
• Elshaikh M, Ljungman M, Ten Haken R, et al. Advances in radiation oncology. Annu Rev Med. 2006;57:19–31.
   PubMed Web of Science ®Google Scholar
• Prise KM, Schettino G, Folkard M, et al. New insights on cell death from radiation exposure. Lancet Oncol. 2005;6:520–528.
   PubMed Web of Science ®Google Scholar
• Duran-Struuck R, Dysko RC. Principles of bone marrow transplantation (BMT): providing optimal veterinary and husbandry care to irradiated mice in BMT studies. J Am Assoc Lab Anim Sci. 2009;48:11–22.
   PubMed Web of Science ®Google Scholar
• Ikehara S. Bone marrow transplantation: a new strategy for intractable diseases. Drugs Today. 2002;38:103–111.
   PubMed Web of Science ®Google Scholar
• Yang PL, Althage A, Chung J, et al. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. PNAS. 2002;99:13825–13830.
   PubMed Web of Science ®Google Scholar
• Pankhurst QA, Connolly J, Jones SK, et al. Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys. 2003;36:R167–R181.
   Web of Science ®Google Scholar
• Nellore RV, Pande PG, Young D, et al. Evaluation of biodegradable microspheres as vaccine adjuvant for hepatitis B surface antigen. J Parenter Sci Technol. 1992;46:176
   PubMedGoogle Scholar
• Singh M, Li XM, McGee JP, et al. Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice. Vaccine. 1997;15:475–481.
   PubMed Web of Science ®Google Scholar
• Mishra D, Dubey V, Asthana A, et al. Elastic liposomes mediated transcutaneous immunization against hepatitis B. Vaccine. 2006;24:4847–4855.
   PubMed Web of Science ®Google Scholar
• Debin A, Kravtzoff R, Santiago JV, et al. Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses. Vaccine. 2002;20:2752–2763.
   PubMed Web of Science ®Google Scholar
• Marcus H, David M, Canaan A, et al. Human/mouse radiation chimera are capable of mounting a human primary humoral response. Blood. 1995;86:398
   PubMed Web of Science ®Google Scholar
• Raney AK, Eggers CM, Kline EF, et al. Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1α-null hepatitis B virus transgenic mice. J. Virol. 2001;75:2900–2911.
   PubMed Web of Science ®Google Scholar
• Yant SR, Meuse L, Chiu W, et al. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet. 2000;25:35–41.
   PubMed Web of Science ®Google Scholar
• Eren R, Lubin I, Terkieltab D, et al. Human monoclonal antibodies specific to hepatitis B virus generated in a human/mouse radiation chimera: the Trimera system. Inmunology. 1998;93:154–161.
   PubMed Web of Science ®Google Scholar
• Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 1999;6:1258–1266.
   PubMed Web of Science ®Google Scholar
• Chen DS. Toward elimination and eradication of hepatitis B. J Gastroenterol Hepatol. 2010;25:19–25.
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Matzke B, Schaller H, et al. High-level hepatitis B virus replication in transgenic mice. J Virol. 1995;69:6158–6169.
   PubMed Web of Science ®Google Scholar
• Shultz LD, Schweitzer PA, Christianson SW, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol. 1995;154:180–191.
   PubMed Web of Science ®Google Scholar
• Budkowska A, Dubreuil P, Poynard T, et al. Anti-pre-S responses and viral clearance in chronic hepatitis B virus infection. Hepatology. 1992;15:26–31.
   PubMed Web of Science ®Google Scholar
• Kakimi K, Guidotti LG, Koezuka Y, et al. Natural killer T cell activation inhibits hepatitis B virus replication in Vivo. J Exp Med. 2000;192:921–930.
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Ishikawa T, Hobbs MV, et al. Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity. 1996;4:25–36.
   PubMed Web of Science ®Google Scholar